NSE
VIJAYA

Vijaya Diagnostic Centre Limited

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Vijaya Diagnostic Centre Limited Stock Price

Vitals

Today's Low:
₹471.25
Today's High:
₹495
Open Price:
₹484.75
52W Low:
₹343
52W High:
₹527.45
Prev. Close:
₹484.15
Volume:
3489

Company Statistics

Market Cap.:
₹51.19 billion
Book Value:
53.298
Revenue TTM:
₹4.76 billion
Operating Margin TTM:
27.37%
Gross Profit TTM:
₹4.21 billion
Profit Margin:
19.62%
Return on Assets TTM:
9.6%
Return on Equity TTM:
16.77%

Company Profile

Vijaya Diagnostic Centre Limited had its IPO on under the ticker symbol VIJAYA.

The company operates in the Healthcare sector and Diagnostics & Research industry. Vijaya Diagnostic Centre Limited has a staff strength of 0 employees.

Stock update

Shares of Vijaya Diagnostic Centre Limited opened at ₹484.75 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹471.25 - ₹495, and closed at ₹473.6.

This is a -2.18% slip from the previous day's closing price.

A total volume of 3,489 shares were traded at the close of the day’s session.

In the last one week, shares of Vijaya Diagnostic Centre Limited have slipped by -4.48%.

Vijaya Diagnostic Centre Limited's Key Ratios

Vijaya Diagnostic Centre Limited has a market cap of ₹51.19 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Vijaya Diagnostic Centre Limited’s revenue was ₹4.76 billion with a gross profit of ₹4.21 billion and an EBITDA of ₹1.99 billion. The EBITDA ratio measures Vijaya Diagnostic Centre Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vijaya Diagnostic Centre Limited’s operating margin was 27.37% while its return on assets stood at 9.6% with a return of equity of 16.77%.

In Q2, Vijaya Diagnostic Centre Limited’s quarterly earnings growth was a positive 50.6% while revenue growth was a positive 16%.

Vijaya Diagnostic Centre Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
54.8302
PEG

Its diluted EPS in the last 12-months stands at ₹9.13 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vijaya Diagnostic Centre Limited’s profitability.

Vijaya Diagnostic Centre Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Vijaya Diagnostic Centre Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.2% and a payout ratio of 15.26%.

Balance sheet and cash flow metrics

Total Assets
₹8.53 billion
Total Liabilities
₹661.69 million
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
15.26%

Vijaya Diagnostic Centre Limited ended 2024 with ₹8.53 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹8.53 billion while shareholder equity stood at ₹5.45 billion.

Vijaya Diagnostic Centre Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹661.69 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹53.38 million in goodwill. Its cash balance stood at ₹241.77 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Vijaya Diagnostic Centre Limited’s total current assets stands at ₹2.76 billion while long-term investments were ₹0 and short-term investments were ₹2.35 billion. Its net receivables were ₹94.89 million compared to accounts payable of ₹277.15 million and inventory worth ₹20.49 million.

In 2024, Vijaya Diagnostic Centre Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Vijaya Diagnostic Centre Limited paid ₹0.15 in dividends in 2024.

Other key metrics

Current Trading Price
₹473.6
52-Week High
₹527.45
52-Week Low
₹343
Analyst Target Price

Vijaya Diagnostic Centre Limited stock is currently trading at ₹473.6 per share. It touched a 52-week high of ₹527.45 and a 52-week low of ₹527.45. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹472.54 and 200-day moving average was ₹424.75 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5498.7% of the company’s stock are held by insiders while 4047.4% are held by institutions.

Frequently Asked Questions About Vijaya Diagnostic Centre Limited

The stock symbol (also called stock or share ticker) of Vijaya Diagnostic Centre Limited is VIJAYA

The IPO of Vijaya Diagnostic Centre Limited took place on

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
₹1.02
-0.06
-5.14%
₹40.7
-0.76
-1.83%
₹21.94
0.79
+3.74%
₹78.55
-2.62
-3.23%
₹17.11
0.13
+0.77%
₹24.96
-0.08
-0.32%
₹759.5
-47.6
-5.9%
₹66.26
-6.09
-8.42%
₹857.15
-3.15
-0.37%
AMERCO (UHALB)
₹52.87
0.04
+0.08%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services, including clinical biochemistry, haematology and immuno-haematology, clinical pathology, histopathology and cytopathology, microbiology, serology, cytogenetics, and molecular pathology; radiology and imaging services comprising magnetic resonance imaging, multi slice CT, CBCT (3D dental), mammography, DEXA/bone densitometry, ultrasound/color doppler, nuclear medicine and PET/CT, and digital X-ray; and cardiology, neurology, and gastroenterology services. The company also provides health checkups and home sample collection services. It operates through a network of 95 diagnostic centers and 1 national reference laboratory, as well as 11 reference laboratories across 15 cities in the states of Telangana, Andhra Pradesh, West Bengal, and the NCR. The company was incorporated in 1981 and is based in Hyderabad, India.

Address